Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1854193 | Reports of Practical Oncology & Radiotherapy | 2014 | 10 Pages |
Abstract
Angiosarcoma remains a difficult management problem with poor loco-regional and distal control. In our study, an overall incidence rate of secondary breast angiosarcoma is 0.065%. Although the prognosis for this disease is poor (typical survival period is 14.5-34 months with a 5-year survival rate of approximately 15%), all the three patients treated at our institute are alive and disease-free at the end of reported period. Finally, it is assumed that the use of breast conserving therapy will increase the incidence of post-irradiation angiosarcoma but the small difference in risk of subsequent sarcoma of the breast cancer patients receiving radiotherapy does not suppress its benefit.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Nuclear and High Energy Physics
Authors
Martina Zemanova, Katarina Machalekova, Monika Sandorova, Elena Boljesikova, Marta Skultetyova, Juraj Svec, Andrej Zeman,